Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting - Jasper Therapeutics (NASDAQ:JSPR)
Oct 24, 2024 View Original Article
- Bias Rating
- Reliability
- Policy Leaning
- Politician Portrayal